Warburg Research Reiterates €56.00 Price Target for Draegerwerk AG & Co KGaA (ETR:DRW3)

Warburg Research set a €56.00 ($65.12) price target on Draegerwerk AG & Co KGaA (ETR:DRW3) in a research note issued to investors on Tuesday, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.

DRW3 has been the topic of several other reports. Nord/LB set a €45.00 ($52.33) target price on Draegerwerk AG & Co KGaA and gave the stock a sell rating in a report on Friday, December 6th. Independent Research set a €52.00 ($60.47) price objective on Draegerwerk AG & Co KGaA and gave the company a sell rating in a research note on Tuesday, November 19th. Hauck & Aufhaeuser set a €38.00 ($44.19) price objective on Draegerwerk AG & Co KGaA and gave the company a sell rating in a research note on Monday. HSBC set a €50.00 ($58.14) price objective on Draegerwerk AG & Co KGaA and gave the company a neutral rating in a research note on Tuesday, November 5th. Finally, Kepler Capital Markets set a €43.00 ($50.00) price objective on Draegerwerk AG & Co KGaA and gave the company a sell rating in a research note on Monday. Four investment analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. The stock has a consensus rating of Sell and a consensus target price of €46.86 ($54.49).

DRW3 opened at €53.85 ($62.62) on Tuesday. The firm has a market cap of $409.26 million and a P/E ratio of 37.24. Draegerwerk AG & Co KGaA has a 52-week low of €38.32 ($44.56) and a 52-week high of €59.40 ($69.07). The company has a debt-to-equity ratio of 31.33, a quick ratio of 1.09 and a current ratio of 1.93. The business’s fifty day moving average is €54.69 and its 200-day moving average is €50.20.

Draegerwerk AG & Co KGaA Company Profile

Dr├Ągerwerk AG & Co KGaA develops equipment and solutions in the fields of medical and safety technology in Europe, Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.

Recommended Story: What are the benefits of a balanced fund?

Analyst Recommendations for Draegerwerk AG & Co KGaA (ETR:DRW3)

Receive News & Ratings for Draegerwerk AG & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Draegerwerk AG & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.